000			01982 a2200589 4500
005			20250515184515.0
264		0	_c20091013
008			200910s 0 0 eng d
022			_a1179-1969
024	7		_a10.2165/11315780-000000000-00000 _2doi
040			_aNLM _beng _cNLM
100	1		_aSmall, David S
245	0	0	_aEffect of age on the pharmacokinetics and pharmacodynamics of prasugrel during multiple dosing: an open-label, single-sequence, clinical trial. _h[electronic resource]
260			_bDrugs & aging _c2009
300			_a781-90 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdenosine Diphosphate
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAging _xphysiology
650	0	4	_aAspirin _xpharmacology
650	0	4	_aBleeding Time
650	0	4	_aBody Mass Index
650	0	4	_aConfidence Intervals
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFasting
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLeast-Squares Analysis
650	0	4	_aMale
650	0	4	_aPiperazines _xadverse effects
650	0	4	_aPlatelet Aggregation _xdrug effects
650	0	4	_aPlatelet Aggregation Inhibitors _xadverse effects
650	0	4	_aPrasugrel Hydrochloride
650	0	4	_aProdrugs _xadverse effects
650	0	4	_aPurinergic P2 Receptor Antagonists
650	0	4	_aStatistics, Nonparametric
650	0	4	_aTablets, Enteric-Coated
650	0	4	_aThiophenes _xadverse effects
650	0	4	_aYoung Adult
700	1		_aWrishko, Rebecca E
700	1		_aErnest, C Steven
700	1		_aNi, Lan
700	1		_aWinters, Kenneth J
700	1		_aFarid, Nagy A
700	1		_aLi, Ying G
700	1		_aSalazar, Daniel E
700	1		_aPayne, Christopher D
773	0		_tDrugs & aging _gvol. 26 _gno. 9 _gp. 781-90
856	4	0	_uhttps://doi.org/10.2165/11315780-000000000-00000 _zAvailable from publisher's website
999			_c19129226 _d19129226